The landscape of dementia diagnosis has evolved considerably with the advent of refined biomarkers, which include amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology several years right before symptoms emerge. Whilst these technological developments depict amazing development in knowledge neurodegenerativ